HALIODX
LIVE

Serial Number

79188392

Owner

HalioDxInvest

Attorney

Cathleen E. Stadecker

Filing Date

Feb 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HALIODX Trademark

Serial Number: 79188392 • Registration: 5435316

HALIODX is a trademark filed by HalioDxInvest on February 25, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HalioDxInvest

163 avenue de Luminy
F-13288 Marseille Cedex 09 , FR

Entity Type: 99

HalioDx (6 trademarks)

163 Avenue de Luminy,
F-13288 Marseille Cédex 09 , FR

Entity Type: 34

VERACYTE (7 trademarks)

PARC SCIENTIFIQUE DE LUMINY

Entity Type: 34

Trademark Details

Filing Date

February 25, 2016

Registration Date

April 3, 2018

Published for Opposition

January 16, 2018

Cancellation Date

October 18, 2024

Goods & Services

Medical analysis services, namely, in vitro testing services for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; health assessment services; genetic testing for medical purposes, namely, in vitro testing services for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition

Downloadable computer software for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; downloadable software in the nature of a mobile application for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition

Pharmaceutical products for use in vitro testing for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for in vitro testing for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostics or identification of biological systems, namely, diagnosis or prognosis of cancer and assessment of patient's response to anti-cancer treatment, monitoring and management of anti-cancer treatment; biological reagents for providing information on diagnostics or identification of biological systems, namely, diagnosis or prognosis of cancer and assessment of patient's response to anti-cancer treatment, monitoring and management of anti-cancer treatment

Medical apparatus and instruments, namely, autostainers, scanners, medical testing devices and diagnostic apparatus for detecting, analyzing or assessing a cancer, tumor or equivalent medical condition

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Nov 30, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 11, 2025 INTS
INVALIDATION PROCESSED
Nov 11, 2025 INPC
NEW REPRESENTATIVE AT IB RECEIVED
Aug 21, 2025 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 18, 2025 INTR
CANCELLED SECTION 71
Oct 18, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 3, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2018 NREP
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Oct 11, 2018 CORR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 11, 2018 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 31, 2018 CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 31, 2018 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 3, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 10, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 10, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 3, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Feb 3, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 18, 2018 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 27, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 27, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2017 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 13, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 13, 2017 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 5, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 5, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 5, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 5, 2017 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 6, 2017 GNFN
FINAL REFUSAL E-MAILED
Sep 6, 2017 GNFR
FINAL REFUSAL WRITTEN
Sep 6, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2017 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2017 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 2, 2017 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2017 CRFA
ASSIGNED TO LIE
Jan 26, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 9, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 9, 2017 REAP
CHANGE OF OWNER RECEIVED FROM IB
Jan 5, 2017 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 22, 2016 ADCH
REFUSAL PROCESSED BY IB
Jul 29, 2016 RFNT
APPLICATION FILING RECEIPT MAILED
Jul 12, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jul 11, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 10, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jul 9, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 7, 2016 REPR